Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Sanford Broadway Clinic
857
mi
from 43215
Fargo, ND
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Sanford Broadway Clinic
857
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
752
mi
from 43215
Tulsa, OK
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
397
mi
from 43215
Allentown, PA
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
397
mi
from 43215
Allentown, PA
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
AnMed Cancer Center
377
mi
from 43215
Anderson, SC
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
AnMed Cancer Center
377
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Upstate Carolina
351
mi
from 43215
Spartanburg, SC
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Upstate Carolina
351
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Avera Cancer Institute
746
mi
from 43215
Sioux Falls, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Avera Cancer Institute
746
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Medical X-Ray Center, PC
747
mi
from 43215
Sioux Falls, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Medical X-Ray Center, PC
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Sioux Valley Hospital at University of South Dakota Medical Center
1160
mi
from 43215
Sioux Falls, SD
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Sioux Valley Hospital at University of South Dakota Medical Center
1160
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited at St. Vincent Hospital
403
mi
from 43215
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited at St. Vincent Hospital
403
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited at St. Mary's Hospital
407
mi
from 43215
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited at St. Mary's Hospital
407
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Mary's Hospital Medical Center - Green Bay
407
mi
from 43215
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Mary's Hospital Medical Center - Green Bay
407
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Vincent Hospital Regional Cancer Center
403
mi
from 43215
Green Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Vincent Hospital Regional Cancer Center
403
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Franciscan Skemp Healthcare - La Crosse Campus
497
mi
from 43215
La Crosse, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Franciscan Skemp Healthcare - La Crosse Campus
497
mi
from 43215
La Crosse, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Bay Area Cancer Care Center at Bay Area Medical Center
425
mi
from 43215
Marinette, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Bay Area Cancer Care Center at Bay Area Medical Center
425
mi
from 43215
Marinette, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited - Oconto Falls
427
mi
from 43215
Oconto Falls, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited - Oconto Falls
427
mi
from 43215
Oconto Falls, WI
Click here to add this to my saved trials
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated:  7/9/2015
Green Bay Oncology, Limited - Sturgeon Bay
405
mi
from 43215
Sturgeon Bay, WI
Everolimus in Treating Patients With Stage IV Melanoma
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
Status: Enrolling
Updated: 7/9/2015
Green Bay Oncology, Limited - Sturgeon Bay
405
mi
from 43215
Sturgeon Bay, WI
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Aurora Presbyterian Hospital
1154
mi
from 43215
Aurora, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Aurora Presbyterian Hospital
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Boulder Community Hospital
1171
mi
from 43215
Boulder, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Boulder Community Hospital
1171
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Penrose Cancer Center at Penrose Hospital
1172
mi
from 43215
Colorado Springs, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Penrose Cancer Center at Penrose Hospital
1172
mi
from 43215
Colorado Springs, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Anthony Central Hospital
1163
mi
from 43215
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Anthony Central Hospital
1163
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Porter Adventist Hospital
1161
mi
from 43215
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Porter Adventist Hospital
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Presbyterian - St. Luke's Medical Center
1162
mi
from 43215
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Presbyterian - St. Luke's Medical Center
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Joseph Hospital
1161
mi
from 43215
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Joseph Hospital
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Rose Medical Center
1158
mi
from 43215
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Rose Medical Center
1158
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Colorado Cancer Research Program, Inc.
1161
mi
from 43215
Denver, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Colorado Cancer Research Program, Inc.
1161
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Swedish Medical Center
1163
mi
from 43215
Englewood, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Swedish Medical Center
1163
mi
from 43215
Englewood, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Front Range Cancer Specialists
1157
mi
from 43215
Fort Collins, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Front Range Cancer Specialists
1157
mi
from 43215
Fort Collins, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
1354
mi
from 43215
Grand Junction, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
1354
mi
from 43215
Grand Junction, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
North Colorado Medical Center
1141
mi
from 43215
Greeley, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
North Colorado Medical Center
1141
mi
from 43215
Greeley, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Sky Ridge Medical Center
1159
mi
from 43215
Lone Tree, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Sky Ridge Medical Center
1159
mi
from 43215
Lone Tree, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Hope Cancer Care Center at Longmont United Hospital
1164
mi
from 43215
Longmont, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Hope Cancer Care Center at Longmont United Hospital
1164
mi
from 43215
Longmont, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
McKee Medical Center
1166
mi
from 43215
Loveland, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
McKee Medical Center
1166
mi
from 43215
Loveland, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Mary - Corwin Regional Medical Center
1160
mi
from 43215
Pueblo, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Mary - Corwin Regional Medical Center
1160
mi
from 43215
Pueblo, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
North Suburban Medical Center
1159
mi
from 43215
Thornton, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
North Suburban Medical Center
1159
mi
from 43215
Thornton, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Exempla Lutheran Medical Center
1167
mi
from 43215
Wheat Ridge, CO
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Exempla Lutheran Medical Center
1167
mi
from 43215
Wheat Ridge, CO
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Rush-Copley Cancer Care Center
299
mi
from 43215
Aurora, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Rush-Copley Cancer Care Center
299
mi
from 43215
Aurora, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
St. Joseph Medical Center
316
mi
from 43215
Bloomington, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
St. Joseph Medical Center
316
mi
from 43215
Bloomington, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Graham Hospital
371
mi
from 43215
Canton, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Graham Hospital
371
mi
from 43215
Canton, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Memorial Hospital
428
mi
from 43215
Carthage, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Memorial Hospital
428
mi
from 43215
Carthage, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Eureka Community Hospital
333
mi
from 43215
Eureka, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Eureka Community Hospital
333
mi
from 43215
Eureka, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Galesburg Clinic, PC
391
mi
from 43215
Galesburg, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Galesburg Clinic, PC
391
mi
from 43215
Galesburg, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Galesburg Cottage Hospital
391
mi
from 43215
Galesburg, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Galesburg Cottage Hospital
391
mi
from 43215
Galesburg, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Mason District Hospital
371
mi
from 43215
Havana, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Mason District Hospital
371
mi
from 43215
Havana, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Hopedale Medical Complex
339
mi
from 43215
Hopedale, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Hopedale Medical Complex
339
mi
from 43215
Hopedale, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Joliet Oncology-Hematology Associates, Limited - West
288
mi
from 43215
Joliet, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Joliet Oncology-Hematology Associates, Limited - West
288
mi
from 43215
Joliet, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
McDonough District Hospital
404
mi
from 43215
Macomb, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
McDonough District Hospital
404
mi
from 43215
Macomb, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
BroMenn Regional Medical Center
316
mi
from 43215
Normal, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
BroMenn Regional Medical Center
316
mi
from 43215
Normal, IL
Click here to add this to my saved trials
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated:  7/9/2015
Community Cancer Center
316
mi
from 43215
Normal, IL
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma
Status: Enrolling
Updated: 7/9/2015
Community Cancer Center
316
mi
from 43215
Normal, IL
Click here to add this to my saved trials